Treatment Set TS350257 - Treatment Set TS350257

Navigation: NDC > Supplier starting with: A > ANTIGEN LABORATORIES, INC.

Field	Value
NDC Code:	49288-0932
Proprietary Name:	Treatment Set TS350257
Suffix:
Non-Proprietary Name:	Treatment Set TS350257
Dosage Form:	INJECTION, SOLUTION
Method:	INTRADERMAL; SUBCUTANEOUS
Original Marketing Date:	31-10-1986
Category Name:	BLA
Application Number:	BLA102223
Labeler:	ANTIGEN LABORATORIES, INC.
Substance Name:	AVENA SATIVA POLLEN; CYNODON DACTYLON POLLEN; FESTUCA PRATENSIS POLLEN; PASCOPYRUM SMITHII POLLEN; PHLEUM PRATENSE POLLEN; SORGHUM HALEPENSE POLLEN
Active Numerator Strength:	.00008; 16; 800; .0004; 800; .00008
Active Ingredient Unit:	g/mL; [BAU]/mL; [BAU]/mL; g/mL; [BAU]/mL; g/mL
Pharm Classes:	Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]
DEA Schedule: